Abstract
We experienced an extremely rare case of recurrent esophageal adenosquamous carcinoma showing cutis, bone and adrenal gland metastases. Furthermore, the patient showed complete remission by chemotherapy and irradiation, with a long-term survival of over 8 years. A 46-year-old man with esophago-gastric junction cancer of clinical stage II was administered two cycles of neo-adjuvant chemotherapy with FP (5FU 800 mg/mm2 Cisplatin 80 mg/mm2 every 3 weeks), subsequently, underwent esophagectomy and mediastinal and celiac lymph node dissection. However, at 1 month after the surgery, he was admitted again due to a 1 cm cutaneous metastasis at the anterior chest wall and left side adrenal gland metastasis. Furthermore, magnetic resonance imaging showed bone metastasis at the second cervical vertebra. He was administered weekly docetaxel at 40 mg/body (3 times every 4 weeks) for 27 cycles. Irradiation therapy (liniac 36 Gy/16Fr) was performed for the vertebral metastasis. The cutaneous and adrenal metastases were diminished and complete remission persisted for over 8 years.
Similar content being viewed by others
References
Hori M, Matsuda T, Shibata A et al (2015) Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 45:884–891
Pennathur A, Gibson MK, Jobe BA et al (2013) Oesophageal carcinoma. Lancet 381:400–412
Gholipour C, Shalchi RA, Abbasi M (2008) A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis Esophagus 21:322–327
Edgren G, Adami HO, Weiderpass E et al (2013) A global assessment of the oesophageal adenocarcinoma epidemic. Gut 62:1406–1414
Yendamuri S, Malhotra U, Hennon M et al (2017) Clinical characteristics of adenosquamous esophageal carcinoma. J Gastrointest Oncol 8:89–95
Chen SB, Weng HR, Wang G et al (2013) Primary adenosquamous carcinoma of the esophagus. World J Gastroenterol 19:8382–8390
The JapanEsophageal Society (2015) Japanese classifications of esophageal cancer, 11th edn. Kanehara, Tokyo
Quint LE, Hepburn LM, Francis IR et al (1995) Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 76:1120–1125
Triantafyllou S, Georgia D, Gavriella-Zoi V et al (2015) Cutaneous metastases from esophageal adenocarcinoma. Int Surg 100:558–561
Alcaraz I, Cerroni L, Rutten A et al (2012) Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol 34:347–393
Schoenlaub P, Sarraux A, Grosshans E et al (2001) Survival after cutaneous metastasis: a study of 200 cases. Ann Dermatol Venereol 128:1310–1315
Kanazawa Y, Fujita I, Kakinuma D et al (2017) Five-year survival after surgical removal and gamma knife stereotactic radiosurgery for a cerebellar metastasis from an esophagogastric junction cancer: a case report and literature review. Vivo 31:1209–1214
Yamamoto Y, Tanaka H, Maruyama T et al (2014) Long-term survival of a patient with esophageal cancer with brain metastasis after multidisciplinary therapy—a case report. Gan To Kagaku Ryoho 41:2006–2009
Kadowaki S, Komori A, Takahari D et al (2015) Clinical characteristics associated with long-term survival in metastatic gastric cancer after systemic chemotherapy. Asian Pac J Cancer Prev 16:5433–5438
Ford HE, Marshall A, Bridgewater JA et al (2014) Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial. Lancet Oncol 15:78–86
Vrana D, Matzenauer M, Neoral C et al (2018) From tumor immunology to immunotherapy in gastric and esophageal cancer. Int J Mol Sci 20(1):13
Ribeiro Gomes J, Schmerling RA, Haddad CK et al (2016) Analysis of the Abscopal effect with Anti-PD1 therapy in patients with metastatic solid tumors. J Immunother 39:367–372
Shaverdian N, Lisberg AE, Bornazyan K, et al (2017) Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Lancet Oncol 18:895–903
Author information
Authors and Affiliations
Contributions
KM, HN, and TO contributed to writing the manuscript. MH, HO, TN, AY, and HW, served as attending physicians of the present patient. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Written Informed consent was obtained from the patient concerning the analysis for MMR staining and publication of this case report and any accompanying images.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Matsuoka, K., Hada, M., Ohmori, H. et al. A long-term survival case with recurrent esophageal adenosquamous carcinoma. Int Canc Conf J 10, 191–196 (2021). https://doi.org/10.1007/s13691-021-00473-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-021-00473-3